No Detail Found!

Role of D-2 receptor antagonist Chlorpromazine in observer rated signs of Acute Opioid Abstinence Syndrome.

Author(s)
Munawar Alam Ansari Department of Pharmacology, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Shahida P. Ahmed Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan
Anila Kazi Institute of Dentistry, Liaquat University of Medical and health Sciences, Jamshoro, Pakistan
Abstract
Chlorpromazine is very common non-opioid treatment option for acute opioid abstinence syndrome at different hospitals and detoxification centers at Karachi. Hence the study was conducted to investigate the efficacy of chlorpromazine compared with placebo in acute opioid abstinence syndrome. Forty healthy opiate-dependent patients seeking inpatient treatment were selected randomly. Of the 40 study patients, 20 were given placebo and 20 were given chlorpromazine 150 mg/day in divided doses under single blind protocol. All patients completed the treatment program and stayed in the hospital for 10 days. Chlorpromazine is ineffective treatment to control the signs of acute opioid abstinence syndrome. There were non- significant differences in the cumulative scores of signs of acute opioid abstinence syndrome between the two groups. The investigators found no benefit of chlorpromazine over placebo in treating acute opioid abstinence syndrome.
Publication Details
Page(s) 39-42
DOI DOI not available
Published Journal: Journal of Basic and Applied Sciences, Volume: 3, Issue: 1, Year: 2007

Request the full text from PASTIC

0

Citations

0

Downloads

25

Views